pubmed-article:18665117 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C0175677 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C1522564 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C0205042 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C0001047 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:18665117 | lifeskim:mentions | umls-concept:C1527362 | lld:lifeskim |
pubmed-article:18665117 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:18665117 | pubmed:dateCreated | 2008-7-30 | lld:pubmed |
pubmed-article:18665117 | pubmed:abstractText | Myocardial ischemia/reperfusion injury in patients undergoing coronary artery by-pass grafting (CABG) involves the reperfusion-induced conversion of reversible injured myocardial and endothelial cells. N-acetylcysteine (NAC) has a potential being the minimization of the impact of reperfusion injury. The aim of this study was to evaluate the effects of intravenous NAC on periprocedural myocardial injury after CABG. | lld:pubmed |
pubmed-article:18665117 | pubmed:language | eng | lld:pubmed |
pubmed-article:18665117 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18665117 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18665117 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18665117 | pubmed:month | Aug | lld:pubmed |
pubmed-article:18665117 | pubmed:issn | 0021-9509 | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:PekerOO | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:PekerTT | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:ErdoganDD | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:OzaydinMM | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:SutcuRR | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:KapanSS | lld:pubmed |
pubmed-article:18665117 | pubmed:author | pubmed-author:IbrisimEE | lld:pubmed |
pubmed-article:18665117 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18665117 | pubmed:volume | 49 | lld:pubmed |
pubmed-article:18665117 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18665117 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18665117 | pubmed:pagination | 527-31 | lld:pubmed |
pubmed-article:18665117 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:meshHeading | pubmed-meshheading:18665117... | lld:pubmed |
pubmed-article:18665117 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18665117 | pubmed:articleTitle | Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. | lld:pubmed |
pubmed-article:18665117 | pubmed:affiliation | Cardiovascular Surgery Department, Suleyman Demirel University Medical Faculty, Isparta, Turkey. | lld:pubmed |
pubmed-article:18665117 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18665117 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |